Keros TherapeuticsKROS
那斯達克 · USD
10.69
-0.58
(-5.15%)
盤中 03/13 01:53 (UTC+8)
03/13 01:53 (UTC+8)
Keros TherapeuticsKROS
10.69
-0.58
(-5.15%)
財務數據
損益表
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.03
- 2.11
- 0.18
- 0.14
- 0.00
- -
- 1687.50
- -41.96
- -55.42
- 948.65
- 684.02
- 6844.31
- -91.40
- -21.50
- -97.30
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 385 | 14,262 | 18,168 | 211,246 | 3,042 | 388 | 37 | 83 | 143 | 8 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 385 | 14,262 | 18,168 | 211,246 | 3,042 | 388 | 37 | 83 | 143 | 8 |
營業費用 | 29,655 | 29,646 | 57,985 | 59,206 | 56,296 | 59,045 | - | 48,566 | 46,598 | 43,288 |
研發費用 | 17,912 | 19,519 | 43,503 | 48,709 | 45,631 | 49,225 | 40,515 | 38,258 | 37,493 | 34,140 |
推銷及管理費用 | 11,743 | 10,127 | 14,482 | 10,497 | 10,665 | 9,820 | 9,961 | 10,308 | 9,105 | 9,148 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -29,270 | -15,384 | -39,817 | 152,040 | -53,254 | -58,657 | -50,439 | -48,483 | -46,455 | -43,280 |
其他收入及費用 | 4,295 | 6,680 | 6,899 | 6,454 | 7,528 | 5,701 | 5,182 | 5,369 | 6,212 | 3,840 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -24,975 | -8,704 | -32,918 | 158,494 | -45,726 | -52,956 | -45,257 | -43,114 | -40,243 | -39,440 |
所得稅 | -1,514 | -1,424 | -2,222 | 10,043 | 300 | - | - | - | - | - |
稅後純益 | -23,461 | -7,280 | -30,696 | 148,451 | -46,026 | -52,956 | -45,257 | -43,114 | -40,243 | -39,440 |
基本每股稅後盈餘(元) | -0.86 | -0.18 | -0.76 | 3.66 | -1.14 | -1.41 | -1.25 | -1.21 | - | -1.33 |
稀釋每股稅後盈餘(元) | -0.38 | -0.18 | -0.76 | 3.62 | -1.12 | -1.42 | -1.25 | -1.21 | -1.34 | -1.33 |
基本平均股數(千股) | 27198.00 | 40623.00 | 40612.00 | 40559.00 | 40337.00 | 37590.00 | 36103.00 | 35685.00 | - | 29668.00 |
稀釋平均股數(千股) | 27198.00 | 40623.00 | 40612.00 | 41021.00 | 40337.00 | 37590.00 | 36103.00 | 35685.00 | - | 29668.00 |
還原基本每股稅後盈餘(元) | -0.86 | -0.18 | -0.76 | 3.66 | -1.14 | -1.41 | -1.25 | -1.21 | - | -1.33 |
還原稀釋每股稅後盈餘(元) | -0.38 | -0.18 | -0.76 | 3.62 | -1.12 | -1.42 | -1.25 | -1.21 | -1.34 | -1.33 |
還原基本平均股數(千股) | 27,198 | 40,623 | 40,612 | 40,559 | 40,337 | 37,590 | 36,103 | 35,685 | - | 29,668 |
還原稀釋平均股數(千股) | 27,198 | 40,623 | 40,612 | 41,021 | 40,337 | 37,590 | 36,103 | 35,685 | - | 29,668 |
EBITDA(千元) | -24,575 | -8,309 | -32,548 | 158,838 | -45,394 | -52,642 | -44,951 | -42,837 | -39,996 | -39,230 |